Technical Analysis for PTN - Palatin Technologies, Inc.

Grade Last Price % Change Price Change
grade D 0.9509 -1.99% -0.02
PTN closed down 3.96 percent on Friday, June 15, 2018, on 62 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
15 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical PTN trend table...

Date Alert Name Type % Chg
Jun 15 180 Bearish Setup Bearish Swing Setup -1.97%
Jun 15 Lower Bollinger Band Walk Weakness -1.97%
Jun 15 Oversold Stochastic Weakness -1.97%
Jun 14 Stochastic Buy Signal Bullish -5.85%
Jun 14 Lower Bollinger Band Walk Weakness -5.85%
Jun 14 Lower Bollinger Band Touch Weakness -5.85%
Jun 14 Oversold Stochastic Weakness -5.85%
Jun 13 200 DMA Support Bullish 1.16%
Jun 13 Lower Bollinger Band Walk Weakness 1.16%
Jun 13 Below Lower BB Weakness 1.16%

Older signals for PTN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Is PTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 6 Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks
Jun 4 Premarket Gainers as of 9:05 am (06/04/2018)
Jun 4 Palatin shares surge 9% premarket after FDA accepts for review treatment for HSDD
Jun 4 FDA accepts Palatin Technologies' NDA review for bremelanotide
Jun 4 Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA
May 29 Was Poltronic SA.’s (WSE:PTN) Earnings Growth Better Than The Industry’s?
May 15 Palatin Technologies' (PTN) CEO Carl Spana on Q3 2018 Results - Earnings Call Transcript
May 15 Edited Transcript of PTN earnings conference call or presentation 15-May-18 3:00pm GMT
May 15 Palatin Tech revenues down 17%; net loss improves in Q1
May 15 Palatin Tech beats by $0.04
See more PTN news...
Indicators
Indicator Value
52 Week High 1.59
52 Week Low 0.354
Average Volume 2,537,531
200-Day Moving Average 0.9406
50-Day Moving Average 1.204
20-Day Moving Average 1.1075
10-Day Moving Average 1.059
Average True Range 0.0765
ADX 16.01
+DI 20.56
-DI 28.04
Chandelier Exit (Long, 3 ATRs ) 1.0505
Chandelier Exit (Short, 3 ATRs ) 1.1545
Upper Bollinger Band 1.2601
Lower Bollinger Band 0.9549
Percent B (%b) 0.05
BandWidth 27.557562
MACD Line -0.055
MACD Signal Line -0.0374
MACD Histogram -0.0176
Fundamentals Value
Market Cap 173.67 Million
Num Shares 179 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -12.13
Price-to-Sales 3.03
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.08
Resistance 3 (R3) 1.09 1.06 1.06
Resistance 2 (R2) 1.06 1.04 1.06 1.05
Resistance 1 (R1) 1.02 1.02 1.01 1.01 1.05
Pivot Point 0.99 0.99 0.99 0.99 0.99
Support 1 (S1) 0.95 0.97 0.94 0.94 0.89
Support 2 (S2) 0.92 0.95 0.92 0.89
Support 3 (S3) 0.88 0.92 0.88
Support 4 (S4) 0.87